3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
84
Ovarian Neoplasms
35
Breast Neoplasms
32
Lung Neoplasms
28
Uterine Cervical Neoplasms
18
Triple Negative Breast Neoplasms
15
Fallopian Tube Neoplasms
15
Carcinoma, Ovarian Epithelial
15
Small Cell Lung Carcinoma
13
Squamous Cell Carcinoma of Head and Neck
10
Neuroblastoma
10
Esophageal Neoplasms
10
Esophageal Squamous Cell Carcinoma
8
Central Nervous System Neoplasms
8
Recurrence
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Retinoblastoma
5
Neoplasm Metastasis
5
Brain Neoplasms
5
Adenocarcinoma of Lung
5
Neoplasms
4
Melanoma
4
Carcinoma, Squamous Cell
4
Testicular Neoplasms
3
Oligodendroglioma
3
Medulloblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Hodgkin Disease
3
Glioblastoma
3
Interventions
Paclitaxel
1
Decitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Primary Malignant Neoplasm of Ovary
×
Carboplatin
×
Clear all
NCT02159820
2014-06-10
DAC and CT
Chinese PLA General Hospital
Phase 2/3
Unknown
500 enrolled